H. Uri Saragovi
Corporate Officer/Principal presso National Cancer Institute
Profilo
H.
Uri Saragovi was the founder of Mimetogen Pharmaceuticals, Inc. (founded in 2004) and Realist Pharma, Inc. (founded in 2015) where he held the titles of Director & Chief Scientific Officer and Chief Scientific Officer, respectively.
Currently, he is a Member at the National Cancer Institute and the National Institutes of Health.
Previously, he worked as a Professor at McGill University and held Principal positions at Mortimer B.
Davis Jewish General Hospital Foundation, Bloomfield Center Alliance, Inc., and QC3.
Dr. Saragovi received his undergraduate degree from Brandeis University in 1984 and his doctorate degree from the University of Miami in 1989.
Posizioni attive di H. Uri Saragovi
Società | Posizione | Inizio |
---|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
Precedenti posizioni note di H. Uri Saragovi
Società | Posizione | Fine |
---|---|---|
Realist Pharma, Inc.
Realist Pharma, Inc. Pharmaceuticals: MajorHealth Technology Realist Pharma, Inc. manufactures pharmaceutical products. It is in an immuno-oncology company delivering breakthrough cancer treatments. The company was founded by Mark de Groot and H. Uri Saragovi in 2015 and is headquartered in Toronto, Canada. | Founder | - |
QC3 | Corporate Officer/Principal | - |
Bloomfield Center Alliance, Inc. | Corporate Officer/Principal | - |
Mortimer B. Davis Jewish General Hospital Foundation | Corporate Officer/Principal | - |
McGill University | Corporate Officer/Principal | - |
Formazione di H. Uri Saragovi
Brandeis University | Undergraduate Degree |
University of Miami | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 7 |
---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Mortimer B. Davis Jewish General Hospital Foundation | |
Bloomfield Center Alliance, Inc. | |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada. | Health Technology |
QC3 | |
Realist Pharma, Inc.
Realist Pharma, Inc. Pharmaceuticals: MajorHealth Technology Realist Pharma, Inc. manufactures pharmaceutical products. It is in an immuno-oncology company delivering breakthrough cancer treatments. The company was founded by Mark de Groot and H. Uri Saragovi in 2015 and is headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- H. Uri Saragovi